Middle East Respiratory Syndrome

Alsolamy, Sami

doi:10.1097/ccm.0000000000000966

Cited by 33 publications

(46 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The MERS is a new viral respiratory disease of humans first described in 2012 and caused by a novel coronavirus (lineage 2C β CoV). [86][87][88][89] The microbiology, epidemiology, and clinical manifestations of SARS and MERS have been compared. 72,[90][91][92]…”

Section: Mers Microbiologymentioning

confidence: 99%

Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)

Weber

Rutala

Fischer

et al. 2016

American Journal of Infection Control

109

View full text Add to dashboard Cite

Over the past several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. New and emerging infectious diseases which are both transmissible from patient-to-patient and virulent with a high mortality include novel coronaviruses (SARS-CoV, MERS-CV), hemorrhagic fever viruses (Lassa, Ebola), and highly pathogenic avian influenza A viruses, A(H5N1) and A(H7N9). All healthcare facilities need to have policies and plans in place for early identification of patients with a highly communicable diseases which are highly virulent, ability to immediately isolate such patients, and provide proper management (e.g., training and availability of personal protective equipment) to prevent transmission to healthcare personnel, other patients and visitors to the healthcare facility.

show abstract

Section: Mers Microbiologymentioning

confidence: 99%

Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)

Weber

Rutala

Fischer

et al. 2016

American Journal of Infection Control

109

View full text Add to dashboard Cite

show abstract

“…Symptomatic cases manifest after an incubation period of 2-14 days [21]. Most severe cases have been reported in adults with chronic comorbidities, including diabetes mellitus, chronic cardiac disease, chronic lung disease, end-stage kidney disease, or immunosuppression [21,22].…”

Section: Clinical Manifestationsmentioning

confidence: 99%

“…Common laboratory abnormalities include leukopenia, lymphocytopenia, and thrombocytopenia, elevated serum creatinine and lactate dehydrogenase, and altered liver enzymes [21]. Initial chest radiographs are abnormal in most symptomatic patients and findings range from minimal abnormalities to extensive bilateral infiltrates [21].…”

Section: Clinical Manifestationsmentioning

confidence: 99%

See 1 more Smart Citation

Critically Ill Patients with Middle East Respiratory Syndrome Coronavirus Infection

Al‐Dorzi

Alsolamy

Arabi

2016

Annual Update in Intensive Care and Emergency Medicine

View full text Add to dashboard Cite

show abstract

“…The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is one of the deadliest and least understood emerging pathogens in the 21st century and continues to pose a threat to global public health because of its high fatality rate [1]. As of January 22, 2016, the World Health Organization (WHO) reported 1,626 laboratory confirmed cases of MERS-CoV, including at least 586 related deaths in 26 countries worldwide [2].…”

Section: Introductionmentioning

confidence: 99%